the financial support of this work by the National Natural Science Foundation of China(22076221,21876208);the Central South University Innovation-Driven Research Programme(2023CXQD022);the Hunan Provincial Science and Technology Plan Project,China(2019TP1001).
Alzheimer’s disease(AD)is one of the neurodegenerative diseases characterized by cognitive dysfunction and behavioral impairment.Early diagnosis of AD serves as a viable means to avoid the onset and progression of th...
Alzheimer’s disease is a neurological disorder marked by the accumulation of amyloid beta(Aβ)aggregates,resulting from mutations in the amyloid precursor protein.The enzymeβ-secretase,also known asβ-site amyloid p...
supported by the National Natural Science Foundation of China(82274301 and 81774377);the Natural Science Foundation of Fujian Province of China(Grant No.2021J01019);the National Key Research and Development Program of China(2016YFC1305903);the Program for New Century Excellent Talents in University of China(NCET-13-0505)(to LW).
Alzheimer’s disease (AD) is a neurodegenerative disease with subtle onset, early diagnosis remains challenging. Accumulating evidence suggests that the emergence of retinal damage in AD precedes cognitive impairment,...
supported by the Intramural Research Program National Institute on Aginq,NIH。
Toxic aggregated amyloid-βaccumulation is a key pathogenic event in Alzheimer’s disease.Treatment approaches have focused on the suppression,deferral,or dispersion of amyloid-βfibers and plaques.Gene therapy has ev...